|AVMXY -- USA Stock|| |
USD 0.91 0.004 0.44%
We currently do not have informatin regarding Stella Sung. This executive tanure with Avita Medical Limited is not currenlty determined.
The company has return on total asset (ROA)
of (67.44) %
which means that it has lost $67.44 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (111.87) %
meaning that it generated substantial loss on money invested by shareholders.
Avita Medical Limited, a medical device company, develops and distributes regenerative products for the treatment of a range of wounds, scars, and skin defects in the Asia Pacific, Europe, the Middle East, Africa, and the Americas. It also offers ReGenerCell for chronic wounds and ReNovaCell for pigmentation. Avita Medical operates under Medical Devices classification in USA and traded on OTC Market. It employs 37 people.Avita Medical Limited (AVMXY) is traded on OTC Market in USA. It is located in 28159 Avenue Stanford and employs 37 people.
Avita Medical Limited Leadership Team
|Damien McDonald, Director, MBA|
|Lou Panaccio, Chairman|
|Stella Sung, Executive|
|Jeremy Cook, Director|
|Ross Saunders, President|
|Fiona Wood, Director|
|Dale Sander, CFO|
|Louis Drapeau, Director, CPA|
|Lorraine Glover, Executive|
|William Marshall, VP|
|Matt McNamara, Director|
|Michael Perry, Director, Ph.D|
|Suzanne Crowe, Director|
|Gabriel Chiappini, Executive|
|Andrew Quick, VP|
|Ian Macpherson, Chairman|
|Tim Rooney, CEO|
|Adam Kelliher, CEO|
|Troy Barring, COO|
Stock Performance Indicators
Most of Macroaxis users are presently bullish on Avita Medical Limited. What is your sentiment towards investing in Avita Medical Limited? Are you bullish or bearish?
and pair trading evaluation for Avita Medical and Ecopetrol S A
. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return